Today, we’d like to share with you an article published recently in The Financial Times of an interview with Mr. Tae-Han Kim, president and CEO of Samsung Biologics, our biopharmaceutical affiliate founded in April 2011.
Read the article: Samsung eyes generic biological medicines
Today, we’d like to share with you an article published recently in The Financial Times of an interview with Mr. Tae-Han Kim, president and CEO of Samsung Biologics, our biopharmaceutical affiliate founded in April 2011.
Read the article: Samsung eyes generic biological medicines
Share article
Related Content